Sabra Healthcare REIT (NASDAQ:SBRA) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Sabra Healthcare REIT (NASDAQ:SBRA) from a hold rating to a sell rating in a research report report published on Friday.

Other research analysts have also issued reports about the company. UBS Group assumed coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 target price on the stock. Cantor Fitzgerald assumed coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Jefferies Financial Group reissued a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT Stock Down 1.1%

SBRA stock opened at $18.82 on Friday. The firm’s 50-day moving average is $19.05 and its two-hundred day moving average is $18.70. The company has a market capitalization of $4.69 billion, a price-to-earnings ratio of 26.14, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $19.97. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.01. The business had revenue of $190.04 million during the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, analysts forecast that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.4%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s payout ratio is 166.67%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Farther Finance Advisors LLC raised its position in Sabra Healthcare REIT by 43.9% during the fourth quarter. Farther Finance Advisors LLC now owns 5,688 shares of the real estate investment trust’s stock valued at $108,000 after buying an additional 1,736 shares during the period. Assetmark Inc. grew its stake in Sabra Healthcare REIT by 15.9% during the 4th quarter. Assetmark Inc. now owns 77,377 shares of the real estate investment trust’s stock valued at $1,466,000 after acquiring an additional 10,641 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Sabra Healthcare REIT by 0.5% in the 4th quarter. State of Alaska Department of Revenue now owns 154,835 shares of the real estate investment trust’s stock valued at $2,930,000 after purchasing an additional 844 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Sabra Healthcare REIT by 1,019.8% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after purchasing an additional 2,736,993 shares in the last quarter. Finally, Diversify Advisory Services LLC boosted its holdings in shares of Sabra Healthcare REIT by 1.0% during the fourth quarter. Diversify Advisory Services LLC now owns 81,861 shares of the real estate investment trust’s stock worth $1,575,000 after purchasing an additional 773 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.